1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Romania Pharmaceutical Report - Q4, 2014

Romania Pharmaceutical Report - Q4, 2014

  • March 2015
  • -
  • Emerging Markets Direct Media Holdings
  • -
  • 15 pages

This report covers the market developments in Q4/2014, FY 2014 and the data available as of February 2015.



The pharmaceutical sales performed above market expectations and increased at double-digit annual pace in Q4/2014 in RON terms. Sales of prescription based medicines (partly or fully subsidized) advanced by 9.6% y/y to RON2.4bn (EUR530mn), while OTC drug sales surged by 19.5% y/y over the quarter. Sales through hospitals also increased by 13.8% y/y in Q4.



In full year 2014, the pharma market accelerated y/y growth compared to the marginal 0.3% y/y advance in 2013 (in local currency), mainly driven by the good performance in Q4. Nonetheless, even though the pharmaceutical sales value increased on an annual basis in 2014, the profitability of pharmaceutical companies deteriorated notably last year, according to market data.



In 2015, pharmaceutical sales are expected to grow by 3.5% y/y, propped by the demand for treatment in areas that are insufficiently covered. On the demand side, the prospects indeed look optimistic, yet the market's future performance is also influenced by factors such as regulatory measures and public spending, which maintain a high degree of volatility.



Key points:

oPharmaceutical sales rise y/y in EUR, RON terms in Q4/2014, driving upwards FY performance

oPharma market value is expected to maintain positive annual performance in 2015

oPharmaceutical imports, exports decline in Jan-Oct 2014

oPharmaceutical retail market value advances 1.7% y/y in 2014, to continue rising this year-study

oZentiva reports double-digit y/y hike of revenues in 2014, profit, driven by rising exports, higher production capacity

oDona pharmacy chain returns to profit in 2014, eyes acquisitions

oSensiblu launches new pharmacy brand targeting low income customers

Table Of Contents

Romania Pharmaceutical Report - Q4, 2014
Contents

Executive summary4

Market overview5

Pharmaceutical sales rise y/y in EUR, RON terms in Q4/2014, driving upwards FY performance5

Pharma market value is expected to maintain positive annual performance in 20157

Sanofi tops pharma companies ranking in 20148

Pharmaceutical imports, exports decline in Jan-Oct 20148

Production of medicines shrinks 1.8% y/y in 201410

Pharmaceutical retail market value advances 1.7% y/y in 2014, to continue rising this year-study10

Producers11

Antibiotice Iasi reports slightly higher sales, profit in 201411

Zentiva reports double-digit y/y hike of revenues in 2014, profit, driven by rising exports, higher production capacity11

Gedeon Richter's sales in Romania down y/y in 201412

Biofarm's sales, profit advance y/y in 201412

Distribution and Retail13

Distributor Polisano targets to increase number of supplied pharmacies by 1,000 by yearend13

Farmaceutica Remedia transfers distribution operations to different company13

Distributor ADM Farm files for insolvency in December 201413

Dona pharmacy chain returns to profit in 2014, eyes acquisitions14

Sensiblu launches new pharmacy brand targeting low income customers14

Ropharma's sales rise 1.7% y/y in 201414



Table 1 Pharma quarterly sales in 2011-2014 (RON bn, EUR bn, y/y, PPP)6

Table 2 Main import countries for pharmaceuticals in Jan-Oct 20149

Table 3 Main export destinations for pharmaceuticals in Jan-Oct 20149

Table 4 Pharmaceutical production in 2011-2014 (monthly, y/y)10

Table 5 Antibiotice SA- Selected financials in 2013-2014 (RON)11

Table 6 Zentiva SA- Selected financials in 2013-2014 (RON)12

Table 7 Biofarm SA- Selected financials in 2013-2014 (RON)12

Table 8 Farmaceutica Remedia SA- Selected financials in 2013-2014 (RON)13

Table 9 Ropharma S.A.- Selected financials in 2013-2014 (RON, y/y)14



Figure 1 Structure of pharma sales in value terms in Q4/2014 vs Q4/2013 (% in total)5

Figure 2 Pharma quarterly sales in 2006-2014 (EUR mn, PPP)6

Figure 3 Structure of pharma sales in value terms in Q4/2014 vs Q4/2013 (% in total)6

Figure 4 Pharmaceutical sales value in 2005-2014 (annual, RON mn, y/y)7

Figure 5 Pharmaceutical sales in 2005-2014 (annual, EUR mn, y/y)7

Figure 6 Top 10 pharma companies by revenues in 2014 (RON mn)8

Figure 7 Pharmaceutical market demand in 2007-2017f (annual, $mn)8

Figure 8 Pharmaceutical products foreign trade in 2003-2014 (monthly, EURmn)9

Figure 9 Pharmaceutical product manufacturing-Foreign trade in 2007-2017f ($mn)9

Figure 10 Pharmaceutical manufacturing index in 2010-2014 (monthly, 2010=100, unadjusted)10


View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.